All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Wavelength-Pharmaceuticals-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Inceptua Group

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Luxembourg

Post An Enquiry

CAMBODIA PHAR-MED 2020

Participation Not Confirmed

Update your events

Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA®

Contact the Supplier

Lead Product(s): Ocriplasmin

Therapeutic Area: Ophthalmology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Large molecule

Partner/Sponsor/Collaborator: Oxurion NV

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement March 13, 2020

Details:

The Agreement with Inceptua will allow Oxurion to focus fully on further advancing its promising next-generation therapeutic pipeline of non-VEGF products for the treatment of diabetic eye disease.